First Time Loading...
D

Definitive Healthcare Corp
NASDAQ:DH

Watchlist Manager
Definitive Healthcare Corp
NASDAQ:DH
Watchlist
Price: 7.06 USD 0.28% Market Closed
Updated: Apr 20, 2024
Section:
 

Wall Street
Price Targets

DH Price Targets Summary
Definitive Healthcare Corp

Wall Street analysts forecast DH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DH is 10.61 USD with a low forecast of 9.09 USD and a high forecast of 12.6 USD.

DH Lowest Forecast
Wall Street Target
9.09 USD
29% Upside
DH Average Forecast
Wall Street Target
10.61 USD
50% Upside
DH Highest Forecast
Wall Street Target
12.6 USD
78% Upside
Lowest
Price Target
9.09 USD
29% Upside
Average
Price Target
10.61 USD
50% Upside
Highest
Price Target
12.6 USD
78% Upside
Definitive Healthcare Corp Competitors:
Price Targets
4483
JMDC Inc
97% Upside
3902
Medical Data Vision Co Ltd
25% Upside
4820
EM Systems Co Ltd
146% Upside
4DX
4DMedical Ltd
90% Upside
4483
JMDC Inc
97% Upside
3902
Medical Data Vision Co Ltd
25% Upside
4820
EM Systems Co Ltd
146% Upside
4DX
4DMedical Ltd
90% Upside
2192
Medlive Technology Co Ltd
44% Upside
4480
Medley Inc
61% Upside
300253
Winning Health Technology Group Co Ltd
62% Upside
G
688246
Goodwill E-Health Info Co Ltd
103% Upside

Revenue
Forecast

Revenue Estimate
Definitive Healthcare Corp

For the last 3 years the compound annual growth rate for Definitive Healthcare Corp's revenue is 29%. The projected CAGR for the next 3 years is 9%.

29%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Definitive Healthcare Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Definitive Healthcare Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
DH intrinsic value, competitors valuation, and company profile.
DCF Valuation
DH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DH stock valuation using valuation multiples.
Wall Street Estimates
DH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DH's stock price target?
Price Target
10.61 USD

According to Wall Street analysts, the average 1-year price target for DH is 10.61 USD with a low forecast of 9.09 USD and a high forecast of 12.6 USD.

What is Definitive Healthcare Corp's Revenue forecast?
Projected CAGR
9%

For the last 3 years the compound annual growth rate for Definitive Healthcare Corp's revenue is 29%. The projected CAGR for the next 3 years is 9%.

ALPHA SPREAD
Join more than 129,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.